tiprankstipranks
Taisho Pharmaceutical Holdings Co Ltd (TAISF)
OTHER OTC:TAISF
US Market
Holding TAISF?
Track your performance easily

Taisho Pharmaceutical Holdings Co (TAISF) Financial Statements

4 Followers

Taisho Pharmaceutical Holdings Co Financial Overview

Taisho Pharmaceutical Holdings Co's market cap is currently ―. The company's EPS TTM is $0.709; its P/E ratio is 83.19; and it has a dividend yield of 1.23%. Taisho Pharmaceutical Holdings Co is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 83.15B-$ 69.07B$ 68.15B$ 69.89B
Gross Profit$ 50.03B-$ 41.80B$ 41.63B$ 43.68B
EBIT$ 12.68B-$ 9.24B$ 5.95B$ 9.30B
EBITDA$ 12.68B-$ 9.24B$ 5.95B$ 9.30B
Net Income Common Stockholders$ 10.02B-$ 5.75B$ 4.15B$ 6.07B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 272.59B$ 0.00$ 276.54B$ 272.27B$ 253.07B
Total Assets$ 946.84B-$ 902.91B$ 888.16B$ 875.76B
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -272.59B$ 0.00$ -276.54B$ -272.27B$ -253.07B
Total Liabilities$ 131.29B-$ 121.32B$ 120.20B$ 115.97B
Stockholders Equity$ 791.34B$ 0.00$ 761.60B$ 748.15B$ 740.73B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Taisho Pharmaceutical Holdings Co Earnings and Revenue History

Taisho Pharmaceutical Holdings Co Debt to Assets

Taisho Pharmaceutical Holdings Co Cash Flow

Taisho Pharmaceutical Holdings Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis